misonneh's biomarker [62 articles] Export

Recent papers added to misonneh's library classified by the tag biomarker. You can also see everyone's biomarker.

	Biomarker Development, Commercialization, and Regulation: Individualization of Medicine Lost in Translation [My Copy] Clinical Pharmacology & Therapeutics, Vol. 81, No. 2. (01 February 2007), pp. 153-155. by C. Wilson, S. Schulz, S. A. Waldman posted to translation design comments biomarker by misonneh on 2009-11-19 05:36:19 as along with 1 person guhjy
	Genomics: We are individuals [My Copy] Nat Rev Cancer, Vol. 9, No. 11. (01 November 2009), pp. 770-771. by Gemma K. Alderton posted to technology subtypes pharmacogenetics metastasis genetics dynamic comments breast biomarker by misonneh on 2009-11-19 02:18:41 as
	MicroRNA dynamics in the stages of tumorigenesis correlate with hallmark capabilities of cancer. [My Copy] Genes & development, Vol. 23, No. 18. (15 September 2009), pp. 2152-2165. by Peter Olson, Jun Lu, Hao Zhang, et al.Anny Shai, Matthew G. Chun, Yucheng Wang, Steven K. Libutti, Eric K. Nakakura, Todd R. Golub, Douglas Hanahan posted to progression mirna metastasis dynamic biomarker by misonneh on 2009-11-19 01:55:36 as along with 3 people and 1 group frohike heliopais valeriehilgers microRNA
	Feature selection and nearest centroid classification for protein mass spectrometry. [My Copy] BMC bioinformatics, Vol. 6 (2005) by Ilya Levner posted to feature_selection cluster biomarker by misonneh on 2009-11-10 06:24:45 as along with 2 people laral mass
	Biomarker identification by feature wrappers. [My Copy] Genome research, Vol. 11, No. 11. (November 2001), pp. 1878-1887. by M. Xiong, X. Fang, J. Zhao posted to feature_selection cluster biomarker array by misonneh on 2009-11-10 06:23:43 as along with 1 person archroad
	Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 5. (1 March 2008), pp. 1368-1376. by Maggie C. Cheang, David Voduc, Chris Bajdik, et al.Samuel Leung, Steven McKinney, Stephen K. Chia, Charles M. Perou, Torsten O. Nielsen posted to triple-negative subtypes hr her2 breast biomarker basal-like by misonneh on 2009-11-10 05:42:06 as along with 4 people songpku NaliniChilkov Zephyrus jfr
	5-methylcytosine--the fifth base of DNA: the fifth wheel on a car or a highly promising diagnostic and therapeutic target in cancer? [My Copy] Disease markers, Vol. 23, No. 1-2. (2007), pp. 1-3. by Martin Widschwendter posted to risk_assessment methylation epigenetics comments chemotherapy biomarker 5mdc by misonneh on 2009-11-04 21:48:18 as
	CD40 signaling predicts response to preoperative trastuzumab and concomitant paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide in HER-2-overexpressing breast cancer. [My Copy] Breast cancer research : BCR, Vol. 9, No. 6. (17 December 2007), R87. by Francisco J. Esteva, Jing Wang, Feng Lin, et al.Jaime A. Mejia, Kai Yan, Kadri Altundag, Vicente Valero, Aman U. Buzdar, Gabriel N. Hortobagyi, W. Fraser Symmans, Lajos Pusztai posted to response prediction neoadjuvant immunity her2 breast biomarker by misonneh on 2009-10-19 08:49:42 as
	Predictive value of tumor Ki-67 expression in two randomized trials of adjuvant chemoendocrine therapy for node-negative breast cancer. [My Copy] Journal of the National Cancer Institute, Vol. 100, No. 3. (6 February 2008), pp. 207-212. by Giuseppe Viale, Meredith M. Regan, Mauro G. Mastropasqua, et al.Fausto Maffini, Eugenio Maiorano, Marco Colleoni, Karen N. Price, Rastko Golouh, Tiziana Perin, R. W. Brown, Anikó Kovács, Komala Pillay, Christian Ohlschlegel, Barry A. Gusterson, Monica Castiglione-Gertsch, Richard D. Gelber, Aron Goldhirsch, Alan S. Coates, International Breast Cancer Study Group posted to prognosis prediction ki67 hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:47:32 as
	Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 8. (10 March 2008), pp. 1275-1281. by Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess, et al.Fabrice André, Attila Tordai, Jaime A. Mejia, W. Fraser Symmans, Ana M. Gonzalez-Angulo, Bryan Hennessy, Marjorie Green, Massimo Cristofanilli, Gabriel N. Hortobagyi, Lajos Pusztai posted to survival prognosis prediction neoadjuvant chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:43 as
	Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance. [My Copy] Breast cancer research and treatment, Vol. 112, No. 3. (9 December 2008), pp. 475-488. by Djuana M. Harvell, Nicole S. Spoelstra, Meenakshi Singh, et al.James L. McManaman, Christina Finlayson, Tzu Phang, Susan Trapp, Lawrence Hunter, Wendy W. Dye, Virginia F. Borges, Anthony Elias, Kathryn B. Horwitz, Jennifer K. Richer posted to resonse resistance neoadjuvant hormone chemotherapy breast biomarker by misonneh on 2009-10-19 08:44:01 as along with 1 person jfr
	Clinical response after two cycles compared to HER2, Ki-67, p53, and bcl-2 in independently predicting a pathological complete response after preoperative chemotherapy in patients with operable carcinoma of the breast. [My Copy] Breast cancer research : BCR, Vol. 10, No. 2. (01 April 2008), R30. by Gunter von Minckwitz, Hans-Peter P. Sinn, Günter Raab, et al.Sibylle Loibl, Jens-Uwe U. Blohmer, Holger Eidtmann, Jörn Hilfrich, Elisabeth Merkle, Christian Jackisch, Serban D. Costa, Angelika Caputo, Manfred Kaufmann, German Breast Group posted to response neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:42:21 as
	The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer. [My Copy] Breast cancer research and treatment, Vol. 116, No. 1. (1 July 2009), pp. 53-68. by Robin L. Jones, Janine Salter, Roger A'Hern, et al.Ash Nerurkar, Marina Parton, Jorge S. Reis-Filho, Ian E. Smith, Mitchell Dowsett posted to prediction neoadjuvant dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:39:43 as along with 1 person Zephyrus
	Changes in tumour biological markers during primary systemic chemotherapy (PST). [My Copy] Anticancer research, Vol. 28, No. 3B. (n 2008), pp. 1797-1804. by Hans Neubauer, Christian Gall, Ulrich Vogel, et al.Rene Hornung, Diethelm Wallwiener, Erich Solomayer, Tanja Fehm posted to response dynamic chemotherapy breast biomarker by misonneh on 2009-10-19 08:37:21 as
	Predicting response to neoadjuvant chemotherapy in breast cancer: molecular imaging, systemic biomarkers and the cancer metabolome (Review). [My Copy] Oncology reports, Vol. 20, No. 4. (October 2008), pp. 699-703. by Suebwong Chuthapisith, Jennifer M. Eremin, Oleg Eremin posted to review response neoadjuvant chemotherapy biomarker by misonneh on 2009-10-19 08:34:52 as
	Tumor-infiltrating lymphocytes predict response to neoadjuvant chemotherapy in patients with breast carcinoma. [My Copy] Cancer investigation, Vol. 26, No. 10. (December 2008), pp. 1024-1031. by Helena Hornychova, Bohuslav Melichar, Marketa Tomsova, Jindøiska Mergancova, Hana Urminska, Ales Ryska posted to response neoadjuvant immunity chemotherapy breast biomarker by misonneh on 2009-10-19 08:17:43 as
	Development of the 21-gene assay and its application in clinical practice and clinical trials. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 26, No. 5. (10 February 2008), pp. 721-728. by Joseph A. Sparano, Soonmyung Paik posted to review randomized_controlled_trial pharmacogenetics oncotypedx genetics design clinic biomarker by misonneh on 2009-10-13 01:05:56 as along with 1 person frohike
	Table of Valid Genomic Biomarkers in the Context of Approved Drug Labels [My Copy] (February 2009) posted to summary pharmacogenetics fda biomarker by misonneh on 2009-10-11 02:14:54 as
	Changes and predictive and prognostic value of the mitotic index, Ki-67, cyclin D1, and cyclo-oxygenase-2 in 710 operable breast cancer patients treated with neoadjuvant chemotherapy. [My Copy] The oncologist, Vol. 13, No. 12. (December 2008), pp. 1235-1245. by Frédérique Penault-Llorca, Catherine Abrial, Inès Raoelfils, et al.Philippe Chollet, Anne Cayre, Marie-Ange A. Mouret-Reynier, Emilie Thivat, Florence Mishellany, Pierre Gimbergues, Xavier Durando posted to response neoadjuvant expression chemotherapy breast biomarker by misonneh on 2009-10-09 08:42:24 as
	Role of Anthracyclines in the Treatment of Early Breast Cancer [My Copy] J Clin Oncol, Vol. 27, No. 28. (1 October 2009), pp. 4798-4808. by Luca Gianni, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna, Gabriel N. Hortobagyi posted to review prognosis pharmacogenetics genetics clinic chemotherapy breast biomarker anthracycline by misonneh on 2009-09-30 04:37:43 as
	Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug use. [My Copy] Pharmacotherapy, Vol. 28, No. 8. (August 2008), pp. 992-998. by Felix W. Frueh, Shashi Amur, Padmaja Mummaneni, et al.Robert S. Epstein, Ronald E. Aubert, Teresa M. DeLuca, Robert R. Verbrugge, Gilbert J. Burckart, Lawrence J. Lesko posted to summary pharmacogenetics fda biomarker by misonneh on 2009-09-29 18:31:30 as
	Clinical trial designs for predictive biomarker validation: theoretical considerations and practical challenges. [My Copy] Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 27, No. 24. (20 August 2009), pp. 4027-4034. by Sumithra J. Mandrekar, Daniel J. Sargent posted to validation review randomized_controlled_trial design biomarker by misonneh on 2009-08-19 00:44:06 as along with 2 people guhjy aezrin
	Emerging biomarkers and new understanding of traditional markers in personalized therapy for breast cancer. [My Copy] Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, No. 24. (15 December 2008), pp. 8019-8026. by Mitch Dowsett, Anita K. Dunbier posted to biomarker breast pharmacogenetics review by misonneh on 2009-01-23 06:03:49 as along with 2 people jfr Zephyrus
	American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer [My Copy] J Clin Oncol, Vol. 25, No. 33. (20 November 2007), pp. 5287-5312. by Lyndsay Harris, Herbert Fritsche, Robert Mennel, et al.Larry Norton, Peter Ravdin, Sheila Taube, Mark R. Somerfield, Daniel F. Hayes, Robert C. Bast posted to biomarker breast review by misonneh on 2008-11-10 02:34:15 as along with 4 people and 1 group songpku Zephyrus jfr lrust Breast Cancer Reading Club
	Clinical biomarkers in drug discovery and development [My Copy] Nature Reviews Drug discovery, Vol. 2, No. 7. (July 2003), pp. 566-580. by R. Frank, R. Hargreaves posted to biomarker review drug_discovery by misonneh on 2008-11-06 06:48:42 as along with 1 person srp33
	Predictive biomarkers of chemotherapy efficacy in colorectal cancer: results from the UK MRC FOCUS trial. [My Copy] Journal of Clinical Oncology, Vol. 26, No. 16. (1 June 2008), pp. 2690-2698. by M. S. Braun, S. D. Richman, P. Quirke, et al.C. Daly, J. W. Adlard, F. Elliott, J. H. Barrett, P. Selby, A. M. Meade, R. J. Stephens, M. K. Parmar, M. T. Seymour posted to biomarker chemotherapy clinic colon pharmacogenetics by misonneh on 2008-10-29 10:19:17 as
	Polychlorinated biphenyl levels in peripheral blood and non-Hodgkin's lymphoma: a report from three cohorts. [My Copy] Cancer research, Vol. 67, No. 11. (1 June 2007), pp. 5545-5552. by L. S. Engel, F. Laden, A. Andersen, et al.P. T. Strickland, A. Blair, L. L. Needham, D. B. Barr, M. S. Wolff, K. Helzlsouer, D. J. Hunter, Q. Lan, K. P. Cantor, G. W. Comstock, J. W. Brock, D. Bush, R. N. Hoover, N. Rothman posted to biomarker exposure lymphoma pcb by misonneh on 2008-10-17 20:54:36 as along with 1 person Zephyrus
	Rules of evidence for cancer molecular-marker discovery and validation. [My Copy] Nature Reviews Cancer, Vol. 4, No. 4. (April 2004), pp. 309-314. by D. F. Ransohoff posted to biomarker guideline by misonneh on 2008-10-17 19:38:23 as along with 3 people and 1 group barmak7282 lwaldron Zephyrus Roswell Cancer Crosstalk
	Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue. [My Copy] Clin Cancer Res, Vol. 12, No. 22. (15 November 2006), pp. 6626-6636. by P. S. Yan, C. Venkataramu, A. Ibrahim, et al.J. C. Liu, R. Z. Shen, N. M. Diaz, B. Centeno, F. Weber, Y. W. Leu, C. L. Shapiro, C. Eng, T. J. Yeatman, T. H. Huang posted to biomarker breast epigenetics gene_specific_methylation ntissue prognosis by misonneh on 2008-10-17 16:38:00 as along with 1 person jfr
	Epigenetic biomarkers and breast cancer: cause for optimism. [My Copy] Clinical Cancer Research, Vol. 12, No. 22. (15 November 2006), pp. 6591-6593. by K. Visvanathan, S. Sukumar, N. E. Davidson posted to biomarker breast circ_dna comments epigenetics target_dna by misonneh on 2008-10-17 16:37:00 as
	The multifaceted circulating endothelial cell in cancer: towards marker and target identification [My Copy] Nature Reviews Cancer, Vol. 6, No. 11. (05 October 2006), pp. 835-845. by Francesco Bertolini, Yuval Shaked, Patrizia Mancuso, Robert S. Kerbel posted to biomarker circ_dna diagnosis prognosis review by misonneh on 2008-10-17 15:26:51 as
	Circulating tumor-specific DNA: a marker for monitoring efficacy of adjuvant therapy in cancer patients. [My Copy] Cancer research, Vol. 65, No. 4. (15 February 2005), pp. 1141-1145. by H. Fiegl, S. Millinger, E. Mueller-Holzner, et al.C. Marth, C. Ensinger, A. Berger, H. Klocker, G. Goebel, M. Widschwendter posted to biomarker breast circ_dna pharmacogenetics prognosis progression tamoxifen by misonneh on 2008-10-08 23:19:52 as along with 1 person c70238
	Genomics and circulating tumor cells: promising tools for choosing and monitoring adjuvant therapy in patients with early breast cancer? [My Copy] Current opinion in oncology, Vol. 17, No. 6. (November 2005), pp. 551-558. by L. Dirix, P. Van Dam, P. Vermeulen posted to biomarker breast circ_dna diagnosis pharmacogenetics review peripheral by misonneh on 2008-10-08 23:18:33 as
	Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma. [My Copy] Journal of Molecular Diagnostics, Vol. 8, No. 1. (February 2006), pp. 22-30. by J. Li, L. Harris, H. Mamon, et al.M. H. Kulke, W. H. Liu, P. Zhu, Mike G. Makrigiorgos posted to biomarker circ_dna peripheral technology by misonneh on 2008-10-08 23:17:38 as
	Cell-free and cell-bound circulating DNA in breast tumours: DNA quantification and analysis of tumour-related gene methylation [My Copy] British Journal of Cancer, Vol. aop, No. current. (25 April 2006) by T. E. Skvortsova, E. Y. Rykova, S. N. Tamkovich, et al.O. E. Bryzgunova, A. V. Starikov, N. P. Kuznetsova, V. V. Vlassov, P. P. Laktionov posted to biomarker breast circ_dna methylation peripheral by misonneh on 2008-10-08 23:16:28 as
	Epigenetic analysis of body fluids and tumor tissues: application of a comprehensive molecular assessment for early-stage breast cancer patients. [My Copy] Annals of the New York Academy of Sciences, Vol. 1075 (September 2006), pp. 211-221. by B. Taback, A. E. Giuliano, R. Lai, et al.N. Hansen, F. R. Singer, K. Pantel, D. S. Hoon posted to biomarker breast circ_dna diagnosis epigenetics prognosis by misonneh on 2008-10-08 23:14:56 as
	Cell-free DNA and RNA in plasma as a new molecular marker for prostate and breast cancer. [My Copy] Ann N Y Acad Sci, Vol. 1075 (September 2006), pp. 235-243. by E. Papadopoulou, E. Davilas, V. Sotiriou, et al.E. Georgakopoulos, S. Georgakopoulou, A. Koliopanos, F. Aggelakis, K. Dardoufas, N. J. Agnanti, I. Karydas, G. Nasioulas posted to biomarker breast circ_dna diagnosis methylation prostate peripheral by misonneh on 2008-10-08 23:13:38 as along with 1 person holmesjo
	Massively parallel bisulphite pyrosequencing reveals the molecular complexity of breast cancer-associated cytosine-methylation patterns obtained from tissue and serum DNA [My Copy] Genome Res. (21 November 2007), gr.6883307. by Yulia Korshunova, Rebecca K. Maloney, Nathan Lakey, et al.Robert W. Citek, Blaire Bacher, Arief Budiman, Jared M. Ordway, Richard W. Mccombie, Jorge Leon, Jeffrey A. Jeddeloh, John D. Mcpherson posted to biomarker breast circ_dna diagnosis methylation peripheral by misonneh on 2008-10-08 23:11:19 as along with 4 people mdperry djkt epigenetics ohara
	Methylation-Based Analysis of Circulating DNA for Breast Tumor Screening [My Copy] Annals of the New York Academy of Sciences, Vol. 1137, No. 1. (August 2008), pp. 232-235. by Rykova, Y. Elena, Tsvetovskaya, et al.A. Galina, Sergeeva, I. Galina, Vlassov, V. Valentin, Laktionov, P. Pavel posted to biomarker breast circ_dna diagnosis methylation peripheral by misonneh on 2008-10-08 23:07:41 as
	Genetic instability in bladder cancer assessed by the comet assay. [My Copy] Journal of the National Cancer Institute, Vol. 95, No. 7. (2 April 2003), pp. 540-547. by M. B. Schabath, M. R. Spitz, H. B. Grossman, et al.K. Zhang, C. P. Dinney, P. J. Zheng, X. Wu posted to biomarker bladder instability peripheral by misonneh on 2008-10-08 22:56:17 as
	Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. [My Copy] Human molecular genetics, Vol. 14, No. 2. (15 January 2005), pp. 235-239. by H. Alazzouzi, E. Domingo, S. González, et al.I. Blanco, M. Armengol, E. Espín, A. Plaja, S. Schwartz, G. Capella, S. Schwartz posted to biomarker colon instability prognosis peripheral by misonneh on 2008-10-08 22:53:01 as
	Dietary carotenoids and genetic instability modify bladder cancer risk. [My Copy] Journal of Nutrition, Vol. 134, No. 12. (December 2004), pp. 3362-3369. by M. B. Schabath, H. B. Grossman, G. L. Delclos, et al.L. M. Hernandez, R. S. Day, B. R. Davis, S. P. Lerner, M. R. Spitz, X. Wu posted to biomarker bladder diet gxe instability peripheral by misonneh on 2008-10-08 22:51:21 as
	Clinical relevance of genetic instability in prostatic cells obtained by prostatic massage in early prostate cancer [My Copy] British Journal of Cancer, Vol. aop, No. current. (11 January 2005) by R. Thuret, K. Chantrel-Groussard, A. Azzouzi, et al.J. Villette, S. Guimard, P. Teillac, P. Berthon, A. Houlgatte, A. Latil, O. Cussenot posted to biomarker instability prognosis prostate peripheral by misonneh on 2008-10-08 22:42:48 as
	Radiosensitivity in breast cancer assessed by the Comet and micronucleus assays [My Copy] British Journal of Cancer, Vol. aop, No. current. (14 March 2006) by C. S. Djuzenova, B. Muhl, M. Fehn, U. Oppitz, B. Muller, M. Flentje posted to biomarker breast instability peripheral by misonneh on 2008-10-08 22:39:05 as
	Variation of ATM protein expression in response to irradiation of lymphocytes in lung cancer patients and controls. [My Copy] Toxicology, Vol. 224, No. 1-2. (5 July 2006), pp. 138-146. by L. Jianlin, H. Jiliang, J. Lifen, et al.Z. Wei, C. Zhijian, C. Shijie, X. Shijie posted to biomarker instability lung peripheral by misonneh on 2008-10-08 22:26:56 as
	Micronucleus frequency in peripheral blood lymphocytes and exfoliated buccal cells of untreated cancer patients. [My Copy] Genetika, Vol. 42, No. 5. (May 2006), pp. 705-710. by I. H. Yildirim, E. Yesilada, S. Yologlu posted to biomarker instability peripheral by misonneh on 2008-10-08 22:25:20 as
	Association of DNA-PK activity and radiation-induced NBS1 foci formation in lymphocytes with clinical malignancy in breast cancer patients. [My Copy] Oncology reports, Vol. 18, No. 4. (October 2007), pp. 873-878. by M. Someya, K. Sakata, Y. Matsumoto, H. Tauchi, H. Narimatsu, M. Hareyama posted to biomarker breast instability peripheral by misonneh on 2008-10-08 22:23:36 as
	Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant for breast cancer from the New York site of the BCFR. [My Copy] Carcinogenesis, Vol. 29, No. 7. (July 2008), pp. 1367-1372. by N. Machella, M. B. Terry, J. Zipprich, et al.I. Gurvich, Y. Liao, R. T. Senie, D. O. Kennedy, R. M. Santella posted to biomarker breast instability peripheral by misonneh on 2008-10-08 22:10:45 as
	Micronuclei frequency in peripheral blood lymphocytes of cancer patients: a meta-analysis. [My Copy] Mutation research, Vol. 659, No. 3. (t 2008), pp. 274-283. by G. Iarmarcovai, M. Ceppi, A. Botta, T. Orsière, S. Bonassi posted to biomarker instability review peripheral by misonneh on 2008-10-08 22:08:36 as
	Spontaneous chromosomal instability in breast cancer families. [My Copy] Cancer genetics and cytogenetics, Vol. 118, No. 1. (1 April 2000), pp. 52-56. by S. K. Roy, A. H. Trivedi, S. R. Bakshi, et al.R. K. Patel, P. H. Shukla, S. J. Patel, J. M. Bhatavdekar, D. D. Patel, P. M. Shah posted to biomarker breast instability peripheral by misonneh on 2008-10-08 22:03:52 as

Note: You may cite this page as: http://www.citeulike.org/user/misonneh/tag/biomarker

Result page: 1 2 Next

review	305
breast	260
genetics	162
epigenetics	161
methylation	153
pharmacogenetics	126
statistics	87
gene_specific_methylation	66
comments	65
gwas	63
biomarker	62
prognosis	60
association	53
tamoxifen	53
chemotherapy	47
moa	47
peripheral	47
gxe	46
diet	43
folate	40
modeling	38
guideline	35
resistance	35
survival	35
meta_analysis	34
global	33
prediction	33
response	32
epidemiology	31
epistasis	30
adr	29
dynamic	28
korean	28
technology	27
diagnosis	26
haplotype	26
prostate	26
time_to_event	25
cyp2d6	23
expression	23
race	23
neoadjuvant	22
circ_dna	21
colon	21
instability	21
environment	20
database	19
prevention	19
progression	18
lung	17
perspective	17
risk_factor	17
line1	16
pooling	16
therapy	16
immunity	14
target_dna	14
1-carbon	13
clinic	13
hr	13
invivo	13
phenotype	13
tool	13
5mdc	12
age	12
randomized_controlled_trial	12
tutorial	12
gxg	11
hematology	11
metastasis	11
mirna	11
pk	11
bladder	10
data_mining	10
estrogen	10
exposure	9
hormone	9
pathway	9
smoking	9
bias	8
cancer	8
design	8
esr1	8
fda	8
gst	8
heterogeneity	8
ivive	8
lifestyle	8
reproductive	8
cnv	7
dnmt	7
etiology	7
her2	7
hla	7
kim_	7
mdr1	7
metabolism	7
mthfr	7
power	7
prenatal	7
subtypes	7
trend	7
alcohol	6
carbamazepine	6
cell	6
cohort	6
cyp450	6
ddi	6
dna_repair	6
drug_discovery	6
epilepsy	6
histone	6
hyper_hypo	6
maternal	6
pcb	6
summary	6
system_biology	6
array	5
benign	5
cervix	5
chemoprevention	5
fundamental_concept_s1	5
inheritance	5
intervention	5
methodology	5
mgmt	5
mhc	5
microarray	5
mortality	5
nos3	5
pet	5
translation	5
asian_populations	4
balanced	4
basal-like	4
biobank	4
bmd	4
cimp	4
cns	4
detection	4
disparities	4
leukemia	4
linkage	4
ntissue	4
observation	4
pathology	4
refractory	4
transport	4
triple-negative	4
tsnp	4
aml	3
antioxidant	3
cluster	3
cyp1a1	3
cytokine	3
demethylation	3
fu	3
glioblastoma	3
hitchhiking	3
intrauterine	3
mds	3
metformin	3
molecular	3
public	3
ros	3
statin	3
sult1a1	3
sult1e1	3
swog	3
toxicity	3
validation	3
allergy	2
apoptosis	2
aromatase_inhibitor	2
aspirin	2
atm	2
bayesian	2
benzopyrene	2
bisphenol	2
brain	2
brca	2
brca12	2
caret	2
childhood	2
classification	2
comt	2
consorcium	2
cyp2c19	2
cyp2e1	2
decitabine	2
definition	2
diabetes	2
egfr_pathway	2
endometrix	2
epigenetic_therapy	2
feature_selection	2
finasteride	2
fprp	2
genotype	2
grail	2
hematopoiety	2
immortalization	2
insilico	2
irinotecan	2
iron	2
isoflavone	2
kawasaki	2
key	2
lymphoma	2
mnsod	2
nqo1	2
nutrition	2
oral	2
ovarian	2
ovary	2
parent_study	2
pharmacodynamic	2
phase	2
polycomb	2
protocol	2
quantitative_traits	2
radiotherapy	2
risk_assessment	2
s8897	2
slco1b1	2
specimen	2
testicular	2
toxicology	2
tpmt	2
ugt	2
wnt	2
abacavir	1
acs	1
aldh1	1
aldh2	1
alkylating_agents	1
alternative	1
anthracycline	1
antidepressant	1
assay	1
azacitidine	1
benzene	1
bmp	1
casp8	1
cat	1
catechol	1
cbr3	1
cdk	1
cell_cycle_control	1
cisplatin	1
cml	1
compliance	1
confounder	1
consortium	1
cyclophosphamide	1
cyp19	1
cyp1a2	1
cyp1b1	1
cyp2c9	1
cyp3a4	1
dag	1
dcic	1
decision	1
diganosis	1
digoxin	1
ecadherin	1
endpoint	1
epidgenetics	1
example	1
family_hx	1
fastsnp	1
fmr1	1
fun	1
glioma	1
gpx1	1
gstp1	1
heritability	1
hif1a	1
histology	1
history	1
hnscc	1
ho1	1
hogg1	1
hpv	1
illumina	1
immunoprecipitation	1
index	1
infection	1
inflammtion	1
integration	1
interleukin	1
invitro	1
journal_club	1
ki67	1
lactation	1
lipidadjust	1
liver	1
mapping	1
maspin	1
mbd2	1
metabolomics	1
meternal	1
methotrexate	1
mining	1
mpo	1
mrp3	1
multiple_myeloma	1
multitest	1
myc	1
networking	1
neurod1	1
nhs	1
no	1
nrf2	1
nsaid	1
nuclear_receptor	1
obesity	1
oncotypedx	1
opg	1
oralscc	1
osteoporosis	1
outcome	1
p53	1
parity	1
paternal	1
pax2	1
peakbmd	1
peripheral_blood	1
pharmacogenomics	1
pharmacokinetic_variability	1
phytoestrogen	1
plink	1
polymapr	1
polyphenol	1
population	1
practice	1
prevalence	1
proression	1
psychoses	1
qsar	1
rank	1
rcc	1
read_	1
resonse	1
rfc	1
s100p	1
sat2	1
scn	1
series	1
sfrp5	1
silencing_rna	1
splicing	1
sputum	1
src	1
steroid	1
stromal_component	1
tea	1
temozolomide	1
tgf	1
tgm2	1
tp53	1
twin_study	1
ugt1a1	1
warfarin	1
xpd	1
xrcc1	1
xrcc3	1

misonneh's biomarker [62 articles] Export

misonneh's tags